Thyrotropin-releasing hormone modulates vasopressin and oxytocin synthesis and release from the hypothalamo-neurohypophysial system of different age male rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 2, 2009, Pages 63-70

  Ciosek, Joanna ^a   Izdebska, K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colchicine; Hypothalamic synthesis; Oxytocin; Thyrotropin releasing hormone; Vasopressin

Indexed keywords

COLCHICINE; NEUROHORMONE; OXYTOCIN; PROTIRELIN; VASOPRESSIN;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DECAPITATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HYPOTHALAMUS; MALE; NERVE CELL; NEUROHYPOPHYSIS; NONHUMAN; RAT;

AGE FACTORS; ANIMALS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INJECTIONS, INTRAVENOUS; MALE; OXYTOCIN; PITUITARY GLAND, POSTERIOR; RATS; RATS, WISTAR; THYROTROPIN-RELEASING HORMONE; VASOPRESSINS;

EID: 68049096038     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Reichlin S. Neural functions of TRH. Acta Endocrinol 1986; 276(Suppl): 21-33.
2. Ciosek, J. Tyreoliberyna (TRH): biosynteza, wystepowanie, receptory, metabolizm. Endokrynol Pol 2004; 55: 608-615.
3. Horita A, Carino MA. Centrally administered TRH produces a vasopressor response in rabbits. Proc West Pharmacol Soc 1977; 20: 303-304. (Pubitemid 8170236)
4. Weitzman RE, Firemark NM, Glatz TH, Fisher DA. Thyrotropin releasing hormone stimulates release of arginine vasopressin and oxytocin in vivo. Endocrinology 1979; 104: 2154-2160.
5. Ciosek J. Wplyw tyreoliberyny na uwalnianie wazopresyny i oksytocyny z ukladu podwzgorzowo-przysadkowego w warunkach in vivo oraz in vitro. Post Hig Med Dosw 2007; 61: 429-437.
6. Kasting NW. Simultaneous and independent release of vasopressin and oxytocin in the rat. Can J Physiol Pharmacol 1988; 66: 22-26. (Pubitemid 18090938)
7. Ciosek J, Guzek JW, Orlowska-Majdak M. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo- neurohypohysial system in dehydrated rats. J Physiol Pharmacol 1993; 44: 293-302. (Pubitemid 23298000)
8. Ciosek J, Orlowska-Majdak M. Thyrotropin-releasing hormone (TRH) inhibits the release of vasopressin but not that of oxytocin from the hypothalamo-neurohypophysial system in haemorrhaged rats. Endocr Regul 1995; 29: 47-55.
9. Ciosek J, Guzek JW. Thyrotropin-releasing hormone affects the oxytocin, vasopressin and prolactin release in female rats during midlactation: relation to suckling. J Physiol Pharmacol 1998; 49: 135-150. (Pubitemid 28168398)
10. Ciosek J. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats. J Physiol Pharmacol 2002; 53: 423-437.
11. Ciosek J, Stempniak B. Thyrotropin-releasing hormone (TRH) inhibits vasopressin and oxytocin release from the rat hypothalamo-neurohypohysial explants in vitro. Acta Neurobiol Exp 1996; 56: 35-40. (Pubitemid 26126125)
12. Silverman WF, Aravich PA, Sladek JR, Sladek CD. Physiological and biochemical indices of neurohypophyseal function in the aging Fischer rat. Neuroendocrinology 1990; 52: 181-190.
13. Terwel D, Markering M, Jolles J. Age-related changes in concentrations of vasopressin in the central nervous system and plasma of the male Wistar rat. Mech Ageing and Develop 1992; 65: 127-136.
14. Zbuzek VK, Zbuzek V, Wu W. The effect of aging on vasopressin system in Fischer 344 rats. Exp Gerontol 1983; 18: 305-311. (Pubitemid 14211702)
15. Zbuzek V, Fuchs AR, Zbuzek VK, Wu W. Neurohypophyseal aging: differential changes in oxytocin and vasopressin release, studied in Fischer 344 and Spraque-Dawley rats. Neuroendocrinology 1988; 48: 619-626. (Pubitemid 19005730)
16. Bourque CW, Oliet SHR, Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 1994; 15: 231-274.
17. Ciosek J. Uwalnianie wazopresyny i oksytocyny z czesci nerwowej przysadki - obecny stan wiedzy. Endokrynol Pol 2000, 51: 113-123.
18. Alonso G. Effects of colchicine on the intraneuronal transport of secretory material priori to the axon: A morphofunctional study in hypothalamic neurosecretory neurons of the rat. Brain Res 1988; 453: 191-203. (Pubitemid 18154764)
19. Robinson AG, Roberts MM, Wayne AE, Janocko LE, Hoffman GE. Total translation of vasopressin and oxytocin in neurohypophysis of rats. Am J Physiol 1989; 257: R109-R117.
20. Ciosek J, Cisowska A. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats. J Physiol Pharmacol 2003; 54: 625-641. (Pubitemid 38029756)
21. Cisowska-Maciejewska A, Ciosek J. Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt-loaded rats. J Physiol Pharmacol 2005; 56: 673-688. (Pubitemid 43127562)
22. Ciosek J, Stempniak B. Thyroliberin and the daily rhythm of vasopressin and oxytocin release from the hypothalamo-neurohypophysial system. Pathophysiology 1998; 5: 131-139. (Pubitemid 28459531)
23. Juszczak M, Bojanowska E, Dabrowski R. Melatonin and the synthesis of vasopressin in pinealectomized male rats. PSEBM 2000; 225: 207-210. (Pubitemid 32041501)
24. Pavo I, Varga C, Szucsa M, Laszlo F. Effects of testosterone on the rat medullary receptor concentration and the antidiuretic response. Life Sci 1995; 56: 1215-1222.
25. Frolkis VV, Golovchenko SF, Medved VI, Frolkis RA. Vasopressin and cardiovascular system in aging. Gerontology 1982; 28: 290-302.
26. Fotheringham AP, Davidson YS, Davies I, Morris JA. Age-associated changes in neuroaxonal transport in the hypothalamo-neurohypophysial system of the mouse. Mech Ageing Dev 1991; 60: 113-121.
27. Roberts MM, Robinson AG, Hoffman GE, Fitzsimmons MD. Vasopressin transport regulation is coupled to the synthesis rate. Neuroendocrinology 1991; 53: 416-422.
28. Zbuzek VK, Zbuzek V, Wu WT. Age-related differences in the incorporation of 3H-arginine into vasopressin in Fischer 344 rats. Exp Gerontol 1987; 22: 113-125. (Pubitemid 17104649)
29. Liu B, Kwok RP, Fernstrom JD. Colchicine-induced increases in immunoreactive neuropeptide levels in hypothalamus: use as an index of biosynthesis. Life Sci 1991; 49: 345-352.
30. Kozniewska E, Romaniuk K. Vasopressin in vascular regulation and water homeostasis in the brain. J Physiol Pharmacol 2008; 59: 109-116.
31. Dayanithi G, Viero C, Shibuya I. The role of calcium in the action and release of vasopressin and oxytocin from CNS neurones/terminals to the heart. J Physiol Pharmacol 2008; 59: 7-26.
32. Siren AL, Lake CR, Feuerstein G. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ Res 1988; 62: 139-154. (Pubitemid 18032084)
33. Ciosek J, Stempniak B. Thyrotropin-releasing hormone (TRH) modifies oxytocin release from the hypothalamo-neurohypophysial system in salt-loaded rats. J Physiol Pharmacol 1995; 46: 169-178.
34. Kanaka S, Yamada M, Satoh T et al. Expression of thyrotropin-releasing hormone (TRH) receptor mRNA in somatotrophs in the rat anterior pituitary. Endocrinology1997; 138: 827-830.
35. Mitsuma T, Rhue N, Sobue G et al. Distribution of thyrotropin releasing hormone receptor in rats: an immunohistochemical study. Endocr Regul 1995; 29: 129-134.
36. Sharif NA. Quantitavive autoradiography of TRH receptor in discrete brain regions of different mammalian species. Ann NY Acad Sci 1985; 553: 147-175.
37. Rondeel JM, Klootwijk W, Linkels E, van Haasteren GA, de Greef WJ, Visser TJ. Regulation of thyrotropin-releasing hormone in the posterior pituitary. Neuroendocrinology 1995; 61: 421-429.
38. Koskinen L-OD. Thyrotropin-releasing hormone and cerebral blood flow. In Vasodilatation, PM Vanhoutte (ed). New York, Raven Press, 1988, pp 75-80.
39. Zlokovic BV, Segal MB, Begley DJ, Davson H, Rakic L. Permeability of the blood-cerebrospinal fluid and bloodbrain barriers to thyrotropin-releasing hormone. Brain Res 1985; 358: 191-199.
40. Okuda C, Tanaka H, Miyazaki M. Cardiovascular effect of intravenously administered thyrotropin-releasing hormone and its concentration in push-pull perfusion of the fourth ventricle in conscious and pentobarbital-anesthetized rats. Life Sci 1988; 42: 1181-1188. (Pubitemid 18069376)
41. Ciosek J, Guzek JW. Thyrotropin-releasing hormone (TRH) and vasopressin and oxytocin release: in vitro as well as in vivo studies. Exp Clin Endocrinol 1992; 100: 152-159. (Pubitemid 23135786)
42. Ciosek J, Stempniak B, Orlowska-Majdak M. Thyrotropin-releasing hormone (TRH) inhibits vasopressin release from the hypothalamo-neurohypophysial system of rats drinking hypertonic saline. Endocr Regul 1993; 27: 29-34. (Pubitemid 23330851)
43. Ciosek J, Orlowska-Majdak M. Thyrotropin-releasing hormone (TRH) inhibits release of vasopressin but not that of oxytocin from the hypothalamo- neurohypophysial system in haemorrhaged rats. Endocr Regul 1995; 29: 47-55.
44. Ciosek J, Stempniak. Thyrotropin-releasing hormone (TRH) and release of neurohypophysial hormones in the rat. Pol J Endocrinol 1997; 48: 23-34.
45. Ali M, Guillon G, Cantan B et al. A comparative study of plasma vasopressin levels and V1 and V2 vasopressin receptor properties in congenital hypothyroid rat under thyroxine or vasopressin therapy. Horm Metab Res 1987; 19: 624-628. (Pubitemid 18014146)
46. Howard RL, Summer S, Rossi N, Kim JK, Schrier RW. Short-term hypothyroidism and vasopressin gene expression in the rat. Am J Kidn Dis 1992; 19: 573-577.
47. Adan RA, Cox JJ, van Kats JP, Burbach JP. Thyroid hormones regulates the oxytocin gene. J Biol Chem 1992; 267: 3771-3777.
48. Vargas F, Baz MJ, Luna JD et al. Urinary excretion of digoxin-like immunoreactive factor and arginine-vasopressin in hyper- and hypo-thyroid rats. Clin Sci 1991; 81: 471-476.
49. Dakine N, Oliver C, Grino M. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing rat. J Neuroendocrinol 2000; 12: 774-783. (Pubitemid 30497104)
50. Mejia S, Morales MA, Zetina ME, Martinez de la Escalera G, Clapp C. Immunoreactive prolactin forms colocalize with vasopressin in neurons of the hypothalamic paraventricular and supraoptic nuclei. Neuroendocrinology 1997; 66: 151-159. (Pubitemid 27356896)
51. Bakowska JC, Morrell JI. The distribution of mRNA for the short form of the prolactin receptor in the forebrain of the female rat. Mol Brain Res 2003; 116: 50-58.
52. Pi XJ, Grattan DR. Differential expression of the two forms of prolactin receptor mRNA within microdissected hypothalamic nuclei of the rat. Mol Brain Res 1998; 59: 1-12.
53. Mejia S, Torner LM, Jeziorski MC et al. Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo- neurohypohyseal system. Endocrine 2003; 20: 155-162. (Pubitemid 36515200)
54. Popeski N, Amir S, Woodside B. Prolactin and oxytocin in the paraventricular and supraoptic nuclei: effects on oxytocin mRNA and nitric oxide synthase. J Neuroendocrinol 2003; 15: 687-696. (Pubitemid 36789968)
55. Parker SL, Armstrong WE, Sladek CD, Grosvenor CE, Crowley WR. Prolactin stimulates the release of oxytocin in lactating rats: evidence for a physiological role via an action at the neural lobe. Neuroendocrinology 1991; 53: 503-510.
56. Cave BJ, Wakerley JB, Luckman SM, Tortonese DJ. Hypothalamic targets for prolactin: assessment of c-Fos induction in tyrosine hydroxylase- and proopiomelanocortin-containing neurons in the rat arcuate nucleus following acute central prolactin administration. Neuroendocrinology 2001; 74: 386-395.
57. Kokay IC, Bull PM, Davis RL, Ludwig M, Grattan DR. Expression of the long form of the prolactin receptor in magnocellular oxytocin neurons is associated with specific prolactin regulation of oxytocin neurons. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1216-R1225.